BRILINTA

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 71610-815
  • Package NDC 71610-815-41
  • Application number NDA022433
  • SPL ID 159d6ad1-edcf-d4da-e063-6294a90a6adb
  • SPL set ID 1547e2b6-8858-178e-e063-6394a90abb23
  • UNII GLH0314RVC
  • RxCUI 1116635
  • RxCUI 1116639

What the source publishes

Labeler
Aphena Pharma Solutions - Tennessee, LLC
Active ingredients
Ticagrelor
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:71610-815_159d6ad1-edcf-d4da-e063-6294a90a6adb
{
  "name": "BRILINTA",
  "splId": "159d6ad1-edcf-d4da-e063-6294a90a6adb",
  "labels": [
    {
      "setId": "1547e2b6-8858-178e-e063-6394a90abb23",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1547e2b6-8858-178e-e063-6394a90abb23",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1547e2b6-8858-178e-e063-6394a90abb23"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Aphena Pharma Solutions - Tennessee, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "5400 TABLET in 1 BOTTLE (71610-815-41)",
      "package_ndc": "71610-815-41",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20240403"
    }
  ],
  "productId": "71610-815_159d6ad1-edcf-d4da-e063-6294a90a6adb",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "71610-815",
  "deaSchedule": null,
  "genericName": "Ticagrelor",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "TICAGRELOR",
      "strength": "90 mg/1"
    }
  ],
  "applicationNumber": "NDA022433",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20110805",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000182142",
      "N0000008832",
      "N0000182143",
      "N0000182141",
      "N0000185503"
    ],
    "unii": [
      "GLH0314RVC"
    ],
    "rxcui": [
      "1116635",
      "1116639"
    ],
    "spl_set_id": [
      "1547e2b6-8858-178e-e063-6394a90abb23"
    ],
    "pharm_class_pe": [
      "Decreased Platelet Aggregation [PE]"
    ],
    "pharm_class_epc": [
      "P2Y12 Platelet Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "P2Y12 Receptor Antagonists [MoA]",
      "Cytochrome P450 3A4 Inhibitors [MoA]",
      "P-Glycoprotein Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Aphena Pharma Solutions - Tennessee, LLC"
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:71610-815_159d6ad1-edcf-d4da-e063-6294a90a6adb"